The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical feasibility of curative surgery after nab-paclitaxel plus gemcitabine-cisplatin chemotherapy in patients with locally advanced cholangiocarcinoma.
 
Sung Hoon Choi
No Relationships to Disclose
 
Beodeul Kang
No Relationships to Disclose
 
Jaekyung Cheon
No Relationships to Disclose
 
Hongjae Chon
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene Cancer Care Links/BMS; Eisai; Menarini; MSD Oncology; Ono Pharmaceutical; Roche; Sanofi; SERVIER
Speakers' Bureau - Bayer; BMS; Celgene/Bristol-Myers Squibb; Eisai; Menarini; Sanofi; SERVIER
Research Funding - Dong-A ST; Roche
 
Dae Jung Kim
No Relationships to Disclose
 
Chang-Il Kwon
No Relationships to Disclose
 
Kwang Hyun Ko
No Relationships to Disclose